查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1931228

高品質胃造瘻管市場按安裝方式、材料、年齡層、最終用戶和分銷管道分類－全球預測，2026-2032年

High Profile Gastrostomy Tube Market by Placement Method, Material, Age Group, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

備受矚目的胃造瘻管市場在 2025 年的價值為 6.9474 億美元，預計到 2026 年將成長至 7.2568 億美元，年複合成長率為 5.21%，到 2032 年將達到 9.9135 億美元。

關鍵市場統計數據
基準年 2025 6.9474億美元
預計年份：2026年 7.2568億美元
預測年份 2032 9.9135億美元
複合年成長率 (%) 5.21%

本執行摘要提供了策略性介紹，清楚概述了臨床團隊的優先事項、供應鏈壓力和產品創新趨勢，定義了目前備受矚目的胃造瘻管的機會。

本執行摘要為備受關注的胃造瘻管裝置提供了重要的背景資訊，幫助臨床團隊和供應鏈領導者重新評估護理路徑和籌資策略。裝置設計的快速發展，以及對病患​​舒適度和降低併發症率的日益重視，正推動著備受關注的胃造瘻管在長期經腸營養管理中發揮越來越重要的作用。同時，門診護理模式的轉變和居家照護的擴展正在改變使用模式和供應商參與的動態。

臨床、材料和分銷領域的新興趨勢正在匯聚，重新定義備受矚目的胃造瘻裝置的設計重點和供應鏈挑戰。

備受矚目的胃造瘻管市場格局正受到多項同時發生且相互依存的變革性變化的影響而重塑。首先，隨著許多手術和後續護理轉移到門診和家庭環境中，易用性、低維護成本以及與遠端醫療支援的整合正成為設計重點，並影響採購標準和培訓通訊協定。其次，材料科學的進步，特別是聚氨酯和矽膠配方的改進，提高了生物相容性和耐用性，使製造商能夠提升患者舒適度並減少器械相關併發症。第三，臨床醫師主導的標準化舉措與支付方主導的品質指標的整合，要求供應商透過結構化的上市後證據和註冊登記來證明其產品的持續表現。

對 2025 年美國關稅變化對醫療設備供應鏈的營運、採購和供應造成的連鎖影響進行全面分析。

美國於2025年實施的新關稅產生了複雜的下游影響，遠不止於簡單的單位成本調整，它也影響籌資策略、分銷經濟效益和庫存管理決策。面對不斷上漲的進口關稅，製造商和經銷商不得不評估替代製造地，盡可能加快近岸外包，並重新評估供應商合約以緩解利潤率壓縮。這種重新平衡通常需要在前置作業時間、單位成本經濟效益和監管合規成本之間做出權衡，尤其對於需要特定材料認證和品管系統的醫療設備更是如此。

可操作的細分分析揭示了最終用戶、投放方式、材料、產品特性、通路和年齡層如何共同影響設備選擇。

細分市場分析揭示了備受追捧的胃造瘻管在臨床應用模式、採購管道和患者人口統計需求方面存在顯著差異。依照最終用戶分析，門診手術中心、居家醫療機構、醫院和專科診所各自展現出不同的臨床工作流程和採購重點。在居家醫療領域，專業居家醫療提供者和自我管理客戶之間的細分凸顯了他們對設備培訓、耐用性和術後支援的不同需求。同時，專科診所內的營養診所則優先考慮先進的營養相容性和設備相容性。通路進一步加劇了市場結構的碎片化。醫院藥房在為住院患者和手術全期患者提供藥物方面發揮著核心作用，而零售藥房則滿足門診病人的處方箋續藥需求。同時，透過直接面對消費者的網站和第三方市場經營的線上藥局正在擴大便利的購買管道，並影響製造商提供產品資訊的方式。

深入剖析美洲、歐洲、中東和非洲以及亞太地區的報銷結構、監管差異以及不斷發展的醫療保健服務模式。

區域趨勢表明，影響臨床實踐模式、採購模式和法規環境的因素多種多樣，且遍及廣闊的地理區域。在美洲，醫療保健系統的特點是公私報銷結構混合，並高度重視門診服務，這促使醫療設備的設計注重高效的手術流程和完善的出院後支援。在歐洲、中東和非洲地區（EMEA），管理體制和採購架構呈現出多元化的特點，有些地區實行集中採購，而有些地區則允許醫院自主採購。這迫使製造商在保持彈性價格設定和監管策略的同時，投資於支持產品在不同臨床環境中應用的臨床證據。亞太市場則以醫療基礎設施的快速現代化、三級醫療中心高頻手術的成長以及對本地製造夥伴關係關係日益成長的需求而著稱，這些需求旨在最佳化成本和合規性之間的權衡。

競爭情報和策略洞察：了解製造商如何將產品創新、臨床證據產生和服務模式結合，從而在不同的臨床環境中脫穎而出。

醫療設備製造商和服務供應商之間的競爭格局日益受到差異化價值主張的驅動，這些價值提案整合了產品設計、臨床證據和生命週期支援服務。主要企業正投資於迭代式產品改進，以提高植入便利性、外部固定可靠性和材料生物相容性，同時擴大註冊研究和真實世界證據項目，以檢驗產品的安全性和易用性。隨著製造商認知到為看護者提供全面的應用支援對於減少併發症和最佳化器械性能至關重要，與分銷網路和臨床培訓機構建立戰略合作夥伴關係正成為商業性運作的核心。

為製造商和醫療服務提供者提供切實可行的、優先排序的建議，以幫助他們將創新、實證實踐和供應鏈韌性融入不斷發展的醫療服務模式中。

為了在不斷變化的醫療模式和貿易環境中創造價值，產業領導者應優先考慮整合產品創新、臨床協作和彈性價值鏈設計的策略。首先，終端使用者應將回饋納入產品開發流程，確保設計改進能夠滿足門診手術中心、居家照護機構和專科診所的實際需求，同時開發專業看護者和患者主導管理場景的培訓材料。此外，他們還應考慮採購管道多元化和關鍵零件近岸外包，以降低關稅波動風險，並提高對臨床需求變化的應對力。

我們採用透明的多層次調查方法，結合與主要相關人員的對話、專家諮詢和系統性文獻綜述，以獲得可操作的見解。

本分析的調查方法融合了與關鍵相關人員的直接對話、有針對性的專家諮詢以及對臨床文獻的系統性回顧，旨在得出具有實際操作意義的見解。主要研究內容包括與不同臨床專科的臨床醫生、來自不同醫療機構的採購主管以及在醫院、零售和線上管道運營的分銷合作夥伴進行訪談和結構化討論。這些訪談和討論有助於我們理解產品應用促進因素、訓練需求和供應鏈考量。此外，我們也與材料科學家和醫療設備工程師進行了專家諮詢，深入了解聚氨酯和矽酮配方之間的權衡取捨，以及這些選擇如何影響產品的性能特徵。

簡要概述重點闡述了設計、證據、分銷和供應韌性將如何決定採納軌跡和相關人員的價值實現。

總之，備受矚目的胃造瘻管市場正處於轉折點，臨床偏好、分銷創新和宏觀經濟因素的交匯正在重塑設備選擇標準和採購行為。以患者為中心的設計、經臨床驗證的性能以及無縫的術後護理將決定哪些解決方案能夠在門診、家庭和專科護理環境中取得成功。通路正在多元化發展，能夠有效整合醫院供應、線上補貨和直接互動的企業將與臨床醫生和看護者建立牢固的長期合作關係。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 高品質胃造瘻管市場依安裝方式分類

  • 經皮視鏡胃造瘻術
  • 放射線引導下胃造瘻術
  • 外科胃造口術

9. 高品質胃造瘻管市場（依材料分類）

  • 聚氨酯
  • 矽酮

第10章 依年齡層別分類的高品質胃造瘻管市場

  • 成人版
  • 老年人
  • 兒童

第11章 高品質胃造瘻管市場（依終端用戶分類）

  • 門診手術中心
  • 居家醫療環境
  • 醫院
  • 專科診所

第12章 高品質胃造瘻管市場（依分銷管道分類）

  • 離線
  • 線上

第13章 各地區優質胃造瘻管市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 高品質胃造瘻管市場（依集團分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國優質胃造瘻管市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國高品質胃造瘻管市場

第17章 中國優質胃造瘻管市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Amsino International, Inc.
  • Avanos Medical, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Coloplast A/S
  • CONMED Corporation
  • ConvaTec Group PLC
  • Cook Medical Incorporated
  • Danone SA
  • Fresenius Kabi AG
  • Halyard Health, Inc.
  • Hollister Incorporated
  • Kimberly-Clark Corporation
  • Mead Johnson Nutrition Company
  • Medtronic plc
  • Moog Inc.
  • Nestle Health Science
  • Smiths Medical
  • Teleflex Incorporated
  • Vygon SA
Product Code: MRR-7B550E008DD0

The High Profile Gastrostomy Tube Market was valued at USD 694.74 million in 2025 and is projected to grow to USD 725.68 million in 2026, with a CAGR of 5.21%, reaching USD 991.35 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 694.74 million
Estimated Year [2026] USD 725.68 million
Forecast Year [2032] USD 991.35 million
CAGR (%) 5.21%

A focused strategic introduction framing clinical priorities, supply chain pressures, and product innovation dynamics that define present opportunities for high profile gastrostomy tubes

This executive summary introduces the critical context for high profile gastrostomy tube devices as clinical teams and supply chain leaders recalibrate care pathways and procurement strategies. Rapid evolution in device design, combined with growing emphasis on patient comfort and reduced complication rates, has elevated the role of high profile gastrostomy tubes in long-term enteral nutrition management. Concurrently, shifts in outpatient care models and expanded home-based services are altering utilization patterns and supplier engagement dynamics.

Clinicians increasingly prioritize device profiles that balance ease of insertion, secure external retention, and patient-centered attributes such as low irritation and compatibility with bedside care routines. Payers and procurement leaders are sharpening focus on total cost of care, procedural resource use, and readmission risk reduction, which amplifies interest in solutions that enable predictable outcomes. Translational research and incremental material innovations are enabling new product iterations, while regulatory scrutiny continues to emphasize post-market surveillance and adverse event reporting. Taken together, these forces set the stage for a period of convergent change across clinical practice, distribution approaches, and commercial strategies that stakeholders must navigate with clearer evidence and operational agility.

Emerging clinical, material, and distribution trends converging to redefine design priorities and supply chain imperatives for high profile gastrostomy devices

The landscape for high profile gastrostomy tubes is being reshaped by several transformative shifts that are simultaneous and interdependent. First, the migration of many procedures and follow-up care into ambulatory and home settings is prompting design priorities around simplicity of use, lower maintenance requirements, and integration with telehealth support, which in turn influences procurement criteria and training protocols. Second, materials science advances-particularly refinements in polyurethane and silicone formulations-are delivering improved biocompatibility and durability, enabling manufacturers to promote enhanced patient comfort and fewer device-related complications. Third, the convergence of clinician-led standardization initiatives and payer-driven quality metrics is pressuring vendors to demonstrate consistent performance through structured post-market evidence and registries.

Additionally, distribution models are fragmenting as digital channels gain traction alongside traditional hospital pharmacy supply. Direct-to-consumer pathways and third-party marketplaces are creating new touchpoints for product education and replenishment, which alters how manufacturers allocate marketing and compliance resources. Finally, geopolitical and trade developments are introducing a new layer of supply chain complexity, compelling stakeholders to pursue diversified sourcing, inventory buffering, and greater transparency across supplier tiers. These shifts collectively demand that clinical, commercial, and operations leaders reexamine assumptions about device selection, training, and long-term support models.

Comprehensive analysis of the cascading operational, procurement, and sourcing effects triggered by the United States tariff changes enacted in 2025 on device supply chains

The introduction of new tariffs by the United States in 2025 has created a complex set of downstream effects that extend beyond immediate unit cost adjustments to influence sourcing strategies, distribution economics, and inventory management decisions. Manufacturers and distributors faced with increased import duties have needed to evaluate alternative manufacturing footprints, accelerate nearshoring where feasible, and reassess supplier contracts to mitigate margin compression. This recalibration often entails trade-offs between lead time, unit economics, and regulatory compliance overhead, particularly for devices that require specific material certifications and quality management systems.

For healthcare providers and procurement teams, tariff-driven cost pressure has prompted closer collaboration with suppliers to identify value engineering opportunities and alternative product configurations that preserve clinical efficacy while reducing exposure to tariffed supply chains. In parallel, distribution partners have adapted contractual terms and service level agreements to accommodate variable landed costs and to maintain continuity of supply for critical care settings. Importantly, many stakeholders have increased emphasis on inventory resilience-expanding safety stocks for essential components and finished devices-while adopting digital procurement tools to track cost variability and supplier performance. Over time, these operational changes are influencing capital allocation decisions and vendor selection criteria across clinical and commercial channels.

Actionable segmentation insights revealing how end user, placement method, material, product profile, distribution channel, and age demographics collectively influence device selection

Segmentation analysis reveals meaningful differentiation in clinical adoption patterns, procurement pathways, and patient population needs for high profile gastrostomy tubes. When analyzed by end user, ambulatory surgical centers, homecare settings, hospitals, and specialty clinics each present distinct clinical workflows and purchasing priorities; within homecare, the split between professional homecare providers and self-management customers underscores divergent needs for device training, durability, and aftercare support, while nutrition clinics within specialty clinics prioritize advanced nutritional compatibility and device interchangeability. Distribution channels further stratify the landscape: hospital pharmacies remain central to inpatient and perioperative provisioning, retail pharmacies serve outpatient refill needs, and online pharmacies-operating through both direct-to-consumer websites and third-party marketplaces-are expanding convenience-driven access and influencing how manufacturers present product information.

Age group segmentation highlights different clinical considerations across adult, geriatric, and pediatric populations, with pediatric care emphasizing size customization and reduced trauma risk, geriatric care prioritizing ease of handling and comorbidity management, and adult care balancing functionality with lifestyle considerations. Placement method distinctions-percutaneous endoscopic gastrostomy, radiologically inserted gastrostomy, and surgical gastrostomy-drive procedural training requirements, compatibility with introducer systems, and post-procedural care protocols. Material choices between polyurethane and silicone affect flexibility, infection risk profiles, and long-term wear, while product profile distinctions between high profile and low profile influence external retention characteristics, cosmetic concerns, and replacement pathways. These segmentation layers interact to shape clinical decision-making, procurement specifications, and value communication strategies across stakeholder groups.

Regionally nuanced insights that connect reimbursement structures, regulatory variability, and care delivery evolution across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics demonstrate heterogeneous drivers that influence clinical practice patterns, procurement models, and regulatory environments across broad geographies. In the Americas, health systems are characterized by mixed public and private reimbursement structures and an emphasis on outpatient care expansion, which encourages device designs that support efficient procedural throughput and robust post-discharge support. Europe, Middle East & Africa present a mosaic of regulatory regimes and procurement frameworks where centralized purchasing in some territories contrasts with hospital-level autonomy in others, prompting manufacturers to maintain flexible pricing and regulatory strategies while investing in clinical evidence to support adoption across varied clinical settings. Asia-Pacific markets are notable for rapid modernization of healthcare infrastructure, high volume procedural growth in tertiary centers, and an increasing appetite for localized manufacturing partnerships to optimize cost and compliance trade-offs.

Across all regions, cross-border supply chain resilience, regulatory harmonization efforts, and digital distribution growth remain common themes that shape product availability and clinician preferences. Regional reimbursement intricacies and local clinical guideline adoption timelines directly affect how quickly new device iterations are integrated into practice. Consequently, commercial and clinical engagement plans must be regionally tailored, combining robust clinical data packages with clear value articulation that addresses the specific purchasing norms, regulatory expectations, and care delivery models characteristic of each geographic area.

Competitive and strategic intelligence revealing how manufacturers are combining product innovation, clinical evidence generation, and service models to differentiate across care settings

Competitive dynamics among device manufacturers and service providers are increasingly driven by differentiated value propositions that combine product design, clinical evidence, and lifecycle support services. Leading organizations are investing in iterative product enhancements that improve insertion ergonomics, external retention reliability, and material biocompatibility while also expanding registries and real-world evidence programs to validate safety and usability. Strategic partnerships with distribution networks and clinical training providers are becoming central to commercial execution, as manufacturers recognize the importance of comprehensive onboarding for clinicians and caregivers to reduce complications and optimize device performance.

Additionally, some companies are pursuing vertical integration across manufacturing and distribution to gain greater control over costs and lead times, whereas others emphasize modular service offerings-such as telehealth-enabled aftercare, replenishment subscriptions, and clinician education programs-to differentiate on lifetime value rather than unit price alone. Mergers and acquisitions activity appears selective and focused on capabilities that accelerate access to new geographies, materials expertise, or digital patient support platforms. Collectively, these strategic choices underscore a shift from transactional selling toward partnership-based models that align commercial success with demonstrable improvements in clinical outcomes and care efficiency.

Practical and prioritized recommendations for manufacturers and providers to align innovation, evidence generation, and supply resilience with evolving care delivery models

Industry leaders should prioritize an integrated approach that aligns product innovation, clinical engagement, and resilient supply chain design to capture value amidst evolving care models and trade dynamics. Begin by embedding end-user feedback loops within product development to ensure that design iterations address the real-world demands of ambulatory surgical centers, homecare providers, and specialty clinics, while tailoring training materials for both professional caregivers and patient-led self-management scenarios. Simultaneously, diversify sourcing and consider nearshoring for critical components to reduce exposure to tariff volatility and to improve responsiveness to clinical demand shifts.

Invest in evidence generation programs that link device attributes to meaningful clinical and operational outcomes, and structure commercial messaging around total cost of care reduction, procedural efficiency, and patient experience improvements rather than simple price points. Expand digital distribution and aftercare capabilities to meet rising demand from direct-to-consumer channels, ensuring compliance controls are integrated with marketplace partnerships. Finally, adopt scenario-based supply planning and flexible inventory strategies to maintain continuity in high-dependency settings while preserving capital efficiency. These actions combined will allow leaders to manage risk, reinforce clinical credibility, and sustain competitive differentiation.

Transparent and multilayered research methodology combining primary stakeholder engagement, expert consultation, and systematic literature review to inform actionable insights

The research methodology underpinning this analysis synthesizes primary stakeholder engagement, targeted expert consultation, and structured review of clinical literature to derive operationally relevant insights. Primary inputs included interviews and structured discussions with clinicians across procedural specialties, procurement leaders from a range of care settings, and distribution partners operating hospital, retail, and online channels, which informed interpretations of adoption drivers, training requirements, and supply chain considerations. Expert consultations with material scientists and device engineers provided perspective on trade-offs between polyurethane and silicone formulations and how those choices influence performance attributes.

Supplementing primary engagement, a systematic review of clinical publications, regulatory guidance, and post-market safety communications was conducted to validate claims of device performance and to identify emerging safety themes. Supply chain and tariff impact analysis drew on trade data patterns and procurement case studies to surface practical mitigation approaches without relying on proprietary market sizing. Throughout, findings were triangulated across sources to ensure internal consistency and to prioritize insights that directly inform clinical decision-making, procurement policy, and commercial strategy.

Concise concluding synthesis highlighting how design, evidence, distribution, and supply resilience will determine adoption trajectories and stakeholder value realization

In conclusion, the high profile gastrostomy tube landscape is at an inflection point where clinical preferences, distribution innovation, and macroeconomic forces intersect to reshape device selection criteria and procurement behavior. Emphasis on patient-centric design, evidenced clinical performance, and seamless aftercare will determine which solutions succeed across ambulatory, home, and specialty environments. Distribution channels are diversifying, and organizations that effectively blend hospital-based supply with online replenishment and direct engagement will secure stronger long-term relationships with clinicians and caregivers.

Operational resilience in the face of trade and tariff fluctuations requires proactive supply chain strategies and closer supplier collaboration. Ultimately, stakeholders who invest in robust evidence, targeted clinician education, and flexible sourcing will be best positioned to navigate the evolving landscape and to translate product innovation into improved patient outcomes and sustainable commercial performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. High Profile Gastrostomy Tube Market, by Placement Method

  • 8.1. Percutaneous Endoscopic Gastrostomy
  • 8.2. Radiologically Inserted Gastrostomy
  • 8.3. Surgical Gastrostomy

9. High Profile Gastrostomy Tube Market, by Material

  • 9.1. Polyurethane
  • 9.2. Silicone

10. High Profile Gastrostomy Tube Market, by Age Group

  • 10.1. Adult
  • 10.2. Geriatric
  • 10.3. Pediatric

11. High Profile Gastrostomy Tube Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Homecare Settings
  • 11.3. Hospitals
  • 11.4. Specialty Clinics

12. High Profile Gastrostomy Tube Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. High Profile Gastrostomy Tube Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. High Profile Gastrostomy Tube Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. High Profile Gastrostomy Tube Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States High Profile Gastrostomy Tube Market

17. China High Profile Gastrostomy Tube Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Amsino International, Inc.
  • 18.7. Avanos Medical, Inc.
  • 18.8. B. Braun Melsungen AG
  • 18.9. Baxter International Inc.
  • 18.10. Becton, Dickinson and Company
  • 18.11. Boston Scientific Corporation
  • 18.12. Cardinal Health, Inc.
  • 18.13. Coloplast A/S
  • 18.14. CONMED Corporation
  • 18.15. ConvaTec Group PLC
  • 18.16. Cook Medical Incorporated
  • 18.17. Danone S.A.
  • 18.18. Fresenius Kabi AG
  • 18.19. Halyard Health, Inc.
  • 18.20. Hollister Incorporated
  • 18.21. Kimberly-Clark Corporation
  • 18.22. Mead Johnson Nutrition Company
  • 18.23. Medtronic plc
  • 18.24. Moog Inc.
  • 18.25. Nestle Health Science
  • 18.26. Smiths Medical
  • 18.27. Teleflex Incorporated
  • 18.28. Vygon S.A.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC GASTROSTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC GASTROSTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC GASTROSTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY RADIOLOGICALLY INSERTED GASTROSTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY RADIOLOGICALLY INSERTED GASTROSTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY RADIOLOGICALLY INSERTED GASTROSTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SURGICAL GASTROSTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SURGICAL GASTROSTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SURGICAL GASTROSTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. GCC HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GCC HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 107. GCC HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 108. GCC HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GCC HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. GCC HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. G7 HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. G7 HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 125. G7 HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 126. G7 HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. G7 HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. G7 HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. NATO HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. NATO HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 131. NATO HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 132. NATO HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. NATO HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. NATO HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. CHINA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. CHINA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY PLACEMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 144. CHINA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 145. CHINA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. CHINA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. CHINA HIGH PROFILE GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)